moxifloxacin has been researched along with Streptococcal Infections in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (55.56) | 29.6817 |
| 2010's | 10 (37.04) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Larruskain, J; Montes, M; Orden, B; Perez-Trallero, E; Tamayo, E | 1 |
| Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
| Cevallos, AV; Keenan, JD; Lee, MD; Lin, YB; Oji, NM; Seitzman, GD | 1 |
| Chhabria, M; Kudaravalli, P; Lesho, E; Pendela, VS | 1 |
| Hong, J; Reyes, HA; Sueldo, C; Witsch, J | 1 |
| Kim, JY; Lee, SJ; Nam, KY | 1 |
| Heidary, G; Somsen, D | 1 |
| Arvieux, C; Dupont, M; Fily, F; Gicquel, T; Jolivet-Gougeon, A; Polard, E; Verdier, MC | 1 |
| Blessmann, M; Cachovan, G; Heiland, M; Platzer, U; Rother, U; Schön, G; Sobottka, I; Stürenburg, E | 1 |
| Attisano, C; Cibinel, M; Furfaro, G; Giardini, F; Grandi, G; Grignolo, FM; Machetta, F; Panepinto, G; Pollino, C; Strani, G | 1 |
| Chandrikakumari, K; Creemers, E; de Leval, L; Frippiat, F; Giot, JB; Leonard, P; Moutschen, M; Mukeba, D | 1 |
| Chapelle, S; Goossens, H; Lammens, C; Malhotra-Kumar, S; Van Heirstraeten, L | 1 |
| Berkner, L; Hazarbassanov, R; Michaeli, A; Regenbogen, M; Varssano, D; Waisbourd, M | 1 |
| Proksch, JW; Ward, KW | 1 |
| Akova, YA; Asena, L; Bozkurt, A; Demiralay, E; Goktaş, MT; Karabay, G; Yaşar, U | 1 |
| Alvarez, M; Diz, P; Limeres, J; López-Meléndez, C; Otero, JL; Saavedra, E; Tomás, I | 1 |
| Georgopoulos, A; Graninger, W; Grisold, AJ; Hirschl, AM; Presterl, E; Reichmann, S | 1 |
| Bogner, JR; Draenert, R; Hellers, J; Kunzelmann, M; Roggenkamp, A | 1 |
| Alvarez, M; Diz, P; Limeres, J; Tomás, I | 1 |
| Athanasopoulos, G; Donta, I; Galani, L; Giamarellou, H; Iliopoulos, D; Pefanis, A; Sakka, V | 1 |
| Farny, K; Michault, A; Picot, S; Simac, C | 1 |
| Kolokotronis, AE; Stefanopoulos, PK | 1 |
| Alvarez Fernández, M; Diz Dios, P; Fernández Feijoo, J; Limeres Posse, J; Medina Henríquez, J; Tomás Carmona, I | 1 |
| Collignon, A; Cruaud, P; Gaudelus, J; Jacquier, H; Lachassinne, E; Poilane, I | 1 |
| Ang, JY; Asmar, BI | 1 |
| Berche, P; Levy, D | 1 |
| Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
2 trial(s) available for moxifloxacin and Streptococcal Infections
| Article | Year |
|---|---|
Radiography-based score indicative for the pathogenicity of bacteria in odontogenic infections.
Topics: Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacteroidaceae Infections; Clindamycin; Double-Blind Method; Female; Fluoroquinolones; Fusobacterium Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Periapical Abscess; Periodontal Abscess; Prospective Studies; Radiography; Staphylococcal Infections; Streptococcal Infections; Tooth Diseases; Virulence; Young Adult | 2014 |
Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clindamycin; Double-Blind Method; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Prospective Studies; Quinolines; Streptococcal Infections; Streptococcus; Tooth Extraction | 2006 |
25 other study(ies) available for moxifloxacin and Streptococcal Infections
| Article | Year |
|---|---|
Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.
Topics: Adult; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Humans; Male; Microbial Sensitivity Tests; Mutation; Prospective Studies; Spain; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
Assessment of Antimicrobial Activity of Dehydrated Amniotic Membrane in Infectious Keratitis: A Small Retrospective Case Series and In Vitro Study.
Topics: Acanthamoeba castellanii; Acanthamoeba Keratitis; Adolescent; Adult; Amnion; Anti-Bacterial Agents; Eye Infections, Bacterial; Humans; Keratitis; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pneumoniae | 2021 |
Case Report: A Polymicrobial Vision-Threatening Eye Infection Associated with Polysubstance Abuse.
Topics: Administration, Ophthalmic; Adult; Anti-Inflammatory Agents; Antioxidants; Ascorbic Acid; Ceftazidime; Cocaine; Cocaine-Related Disorders; Coinfection; Dopamine Uptake Inhibitors; Doxycycline; Endophthalmitis; Female; Gram-Positive Bacterial Infections; Humans; Keratitis; Kingella; Linezolid; Moxifloxacin; Neisseriaceae Infections; Ophthalmic Solutions; Prednisone; Propionibacterium acnes; Streptococcal Infections; Streptococcus; Substance Abuse, Intravenous; Tobramycin; Vancomycin; Voriconazole | 2020 |
Posterior reversible encephalopathy in an adult patient with poststreptococcal glomerulonephritis.
Topics: Adult; Anti-Bacterial Agents; Brain; Diagnosis, Differential; Fluoroquinolones; Glomerulonephritis; Humans; Magnetic Resonance Imaging; Male; Moxifloxacin; Pneumonia, Bacterial; Posterior Leukoencephalopathy Syndrome; Streptococcal Infections | 2017 |
Systemic Moxifloxacin in Streptococcus viridans Endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Injections, Intraventricular; Moxifloxacin; Rabbits; Streptococcal Infections; Treatment Outcome; Viridans Streptococci; Vitreous Body | 2019 |
Rapid onset of orbital cellulitis after uncomplicated strabismus surgery.
Topics: Administration, Ophthalmic; Ampicillin; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Esotropia; Eye Infections, Bacterial; Humans; Male; Moxifloxacin; Oculomotor Muscles; Ophthalmic Solutions; Orbital Cellulitis; Postoperative Complications; Streptococcal Infections; Streptococcus pyogenes; Sulbactam; Tomography, X-Ray Computed; Vancomycin | 2019 |
Moxifloxacin-rifampicin combination for the treatment of non-staphylococcal Gram-positive orthopedic implant-related infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Combinations; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Hip Prosthesis; Humans; Male; Middle Aged; Moxifloxacin; Propionibacteriaceae; Prosthesis-Related Infections; Retrospective Studies; Rifampin; Streptococcal Infections; Treatment Outcome | 2019 |
Severe Ocular Bacterial Infections: A Retrospective Study Over 13 Years.
Topics: Anti-Bacterial Agents; Conjunctiva; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus | 2017 |
Report of a case of Streptococcus agalactiae mycotic aneurysm and review of the literature.
Topics: Aged; Aneurysm, Infected; Anti-Infective Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Aza Compounds; Fluoroquinolones; Humans; Male; Moxifloxacin; Quinolines; Streptococcal Infections; Streptococcus agalactiae; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antigens, Bacterial; Aza Compounds; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Belgium; Carrier Proteins; Child; Child, Preschool; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fluoroquinolones; Humans; Infant; Membrane Transport Proteins; Middle Aged; Moxifloxacin; Quinolines; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2009 |
Late-onset laser in situ keratomileusis-related corneal ulcer--a case series.
Topics: Administration, Topical; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Corneal Ulcer; Eye Infections, Bacterial; Fluoroquinolones; Humans; Keratomileusis, Laser In Situ; Male; Middle Aged; Moxifloxacin; Quinolines; Retrospective Studies; Staphylococcal Infections; Streptococcal Infections; Surgical Flaps; Time Factors | 2009 |
Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Area Under Curve; Aza Compounds; Azepines; Conjunctivitis, Bacterial; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Rabbits; Staphylococcal Infections; Streptococcal Infections | 2010 |
Ocular pharmacokinetics, safety and efficacy of intracameral moxifloxacin 0.5% solution in a rabbit model.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Disease Models, Animal; Dose-Response Relationship, Drug; Endophthalmitis; Epithelium, Corneal; Eye Infections, Bacterial; Fluoroquinolones; Injections, Intraocular; Microscopy, Electron, Transmission; Moxifloxacin; Phacoemulsification; Quinolines; Rabbits; Staphylococcal Infections; Streptococcal Infections; Vitreous Body | 2013 |
In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Drug Resistance, Bacterial; Female; Fluoroquinolones; Focal Infection, Dental; Humans; Iatrogenic Disease; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Quinolines; Spain; Statistics, Nonparametric; Streptococcal Infections; Streptococcus; Tooth Extraction | 2004 |
Viridans streptococci in endocarditis and neutropenic sepsis: biofilm formation and effects of antibiotics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Biofilms; Blood; Culture Media; Endocarditis, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Penicillins; Quinolines; Streptococcal Infections; Teicoplanin; Viridans Streptococci | 2005 |
Infected cat-bite wound treated successfully with moxifloxacin after failure of parenteral cefuroxime and ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Aza Compounds; Bites and Stings; Cats; Cefuroxime; Ciprofloxacin; Female; Fluoroquinolones; Humans; Middle Aged; Moxifloxacin; Pasteurella Infections; Quinolines; Streptococcal Infections; Treatment Failure; Wound Infection | 2005 |
Empirical antimicrobial therapy for odontogenic infections.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; beta-Lactam Resistance; Fluoroquinolones; Focal Infection, Dental; Humans; Microbial Sensitivity Tests; Moxifloxacin; Periapical Abscess; Quinolines; Streptococcal Infections; Streptococcus | 2005 |
Successful moxifloxacin prophylaxis against experimental streptococcal aortic valve endocarditis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Aortic Valve; Aza Compounds; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Fluoroquinolones; Heart Valve Diseases; Moxifloxacin; Quinolines; Rabbits; Streptococcal Infections; Streptococcus oralis | 2005 |
[Antimicrobial resistance of Streptococcus pneumoniae strains isolated in the Reunion Island during 2004].
Topics: Aza Compounds; beta-Lactams; Cephalosporin Resistance; Cephalosporins; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Ketolides; Moxifloxacin; Penicillin Resistance; Quinolines; Retrospective Studies; Reunion; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Controversies in antibiotic choices for odontogenic infections.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria, Anaerobic; Bacterial Infections; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Focal Infection, Dental; Humans; Moxifloxacin; Quinolines; Spain; Streptococcal Infections; Viridans Streptococci | 2006 |
[In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci].
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteremia; Cefotaxime; Drug Therapy, Combination; Fluoroquinolones; Humans; Infant, Newborn; Meningitis, Bacterial; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Serotyping; Streptococcal Infections; Streptococcus agalactiae | 2007 |
Multidrug-resistant viridans streptococcus (MDRVS) osteomyelitis of the mandible successfully treated with moxifloxacin.
Topics: Adult; Anti-Infective Agents; Aza Compounds; Debridement; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Mandibular Diseases; Moxifloxacin; Osteomyelitis; Quinolines; Streptococcal Infections; Viridans Streptococci | 2008 |
Bactericidal activity of moxifloxacin against pneumococci.
Topics: Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Penicillins; Quinolines; Streptococcal Infections; Streptococcus pneumoniae | 2001 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Penicillins; Quinolines; Streptococcal Infections; Streptococcus | 2001 |